
Migovib-SR 40 Tablet
Marketer
Vibcare Pharma Pvt Ltd
Salt Composition
Propranolol (40mg)
Overview Migovib-SR 40 Tablet
Propranolol XL 40mg tablets alleviate anxiety symptoms and reduce tremors. This medication also serves to prevent migraine attacks, angina (chest pain linked to the heart), and gastrointestinal bleeding stemming from portal hypertension (high blood pressure in the liver). Propranolol XL 40mg may additionally manage hypertension and certain arrhythmias (irregular heartbeats). Dosage is tailored to your specific condition and response. Always adhere to your physician's prescribed regimen, taking the medication on an empty stomach at roughly the same time daily. Continue treatment even if you feel well, as ongoing benefits persist. Abrupt cessation may exacerbate your condition. Common side effects include fatigue, weakness, Raynaud's phenomenon (cold extremities), bradycardia (slow heartbeat), paresthesia (numbness in fingers), and dyspnea (shortness of breath). Nausea, vomiting, and diarrhea may also occur. Consult your doctor if side effects are bothersome or persistent; most are transient and subside with continued use. Avoid using this medication if you have asthma, significant bradycardia, or severe heart disease including heart failure. Discuss its use with your physician if you have kidney or liver impairment or COPD. Alcohol consumption may interfere with the medication's efficacy and should be avoided. Refrain from driving if dizziness occurs. Consult your doctor regarding the safety of this medication during pregnancy or breastfeeding.
Primary Ingredients of Migovib-SR 40 Tablet
No text provided to rephrase.
Uses of Migovib-SR 40 Tablet
Managing angina (chest pain stemming from heart issues) | Addressing cardiac arrhythmias | Avert myocardial infarction | Hypertension (high blood pressure) management | Anxiety treatment | Tremor control | Migraine prevention | Pheochromocytoma management
Major Benefits of Migovib-SR 40 Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Swallow the Migovib-SR 40 Tablet whole; do not chew, crush, or break it. Administer this medication on an empty stomach. Refrain from consuming Migovib-SR 40 Tablet with meals high in fat, including those containing olive oil, nuts and seeds (like Brazil nuts), dark chocolate, butter, or meat.
Common Side effects of Migovib-SR 40 Tablet:
- Cold extremities
- Sleep disturbance
- Fatigue
- Slow heart rate
- Nightmares
How to use Migovib-SR 40 Tablet:
Administer Migovib-SR 40 Tablet precisely as your physician directs, both in terms of dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume this medication on an empty stomach. Refrain from taking Migovib-SR 40 Tablet with high-fat foods, including olive oil, nuts and seeds (like Brazil nuts), dark chocolate, butter, and meat.
How Migovib-SR 40 Tablet works:
Migovib-SR 40, a tablet containing the beta-blocker propranolol, modifies the body's reaction to nerve signals, particularly within the cardiovascular system. This reduces heart rate and improves the heart's pumping efficiency, thus preventing irregular heartbeats. Simultaneously, it dilates blood vessels, enhancing circulation and mitigating both angina and migraine. Although the precise mechanism for tremor reduction remains unclear, it's hypothesized that Migovib-SR 40 blocks nerve impulses to the affected muscles. By counteracting the effects of adrenaline and noradrenaline—brain-produced chemicals that elevate heart rate and induce anxiety—it provides anxiety relief. In pheochromocytoma treatment, Migovib-SR 40 can mitigate the impact of excessive adrenaline hormones, reducing the risk of dangerously elevated blood pressure during tumor resection.
SAFETY ADVICE
AlcoholUNSAFE
Combining Migovib-SR 40 Tablet with alcohol is not recommended due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
Using Migovib-SR 40 Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers before prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release migovib 40 mg tablets are likely not safe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
For individuals with severe kidney impairment, the use of Migovib-SR 40mg tablets requires careful consideration. Dosage modification of Migovib-SR 40mg tablets might be necessary. Physician consultation is advised.
LiverCAUTION
For individuals with hepatic impairment, Migovib-SR 40 mg tablets require careful administration. Dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Migovib-SR 40 Tablet :
Should you forget to take a Migovib-SR 40 Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed tablet and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Migovib-SR 40 Tablet
| Label | Value |
|---|---|
| Chemical Type | Naphthalene derivatives |
| Developing Habits | No. |
| Type of Therapy | Heart |
